Changjiang Pharmaceutical Group Co (SZSE:300391) Total Liabilities : ¥2,553.2 Mil (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Changjiang Pharmaceutical Group Co Total Liabilities?

Changjiang Pharmaceutical Group Co's Total Liabilities for the quarter that ended in Mar. 2025 was ¥2,553.2 Mil.

Changjiang Pharmaceutical Group Co's quarterly Total Liabilities increased from Sep. 2024 (¥2,353.91 Mil) to Dec. 2024 (¥2,417.07 Mil) and increased from Dec. 2024 (¥2,417.07 Mil) to Mar. 2025 (¥2,553.25 Mil).

Changjiang Pharmaceutical Group Co's annual Total Liabilities increased from Dec. 2022 (¥1,913.97 Mil) to Dec. 2023 (¥2,428.44 Mil) but then declined from Dec. 2023 (¥2,428.44 Mil) to Dec. 2024 (¥2,417.07 Mil).

Changjiang Pharmaceutical Group Co Total Liabilities Historical Data

The historical data trend for Changjiang Pharmaceutical Group Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changjiang Pharmaceutical Group Co Total Liabilities Chart

Changjiang Pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

3,240.94

2,605.18

1,913.97

2,428.44

2,417.07

Changjiang Pharmaceutical Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															2,495.77	2,332.19	2,353.91	2,417.07	2,553.25

Changjiang Pharmaceutical Group Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Changjiang Pharmaceutical Group Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1924.645	+	(445.787	+	46.641
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	2,417.1

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	1995.718	-	-421.355
	=	2,417.1

Changjiang Pharmaceutical Group Co's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2045.193	+	(445.798	+	62.257
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	2,553.2

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	2042.497	-	-510.752
	=	2,553.2

Changjiang Pharmaceutical Group Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Changjiang Pharmaceutical Group Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Changjiang Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changjiang Pharmaceutical Group Co Ltd (SZSE:300391) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

Shouguang Development Zone, Shandong, CHN, 262700

Website

http://www.chinakangyue.com

Changjiang Pharmaceutical Group Co Ltd is engaged in the production and sales of decoction pieces of traditional Chinese medicine and medicinal capsules, as well as the wholesale of medicines, health products and medical devices.

Executives

Zong Jun	Directors, executives
Wang Hang	Executives

Changjiang Pharmaceutical Group Co Headlines

No Headlines